0001209191-23-000300.txt : 20230103 0001209191-23-000300.hdr.sgml : 20230103 20230103170120 ACCESSION NUMBER: 0001209191-23-000300 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230101 FILED AS OF DATE: 20230103 DATE AS OF CHANGE: 20230103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fuhrman Alan CENTRAL INDEX KEY: 0001303521 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40800 FILM NUMBER: 23503036 MAIL ADDRESS: STREET 1: C/O AMBIT BIOSCIENCES CORPORATION STREET 2: 11080 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tyra Biosciences, Inc. CENTRAL INDEX KEY: 0001863127 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831476348 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: (619) 728-4760 MAIL ADDRESS: STREET 1: 2656 STATE STREET CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-01 0 0001863127 Tyra Biosciences, Inc. TYRA 0001303521 Fuhrman Alan C/O TYRA BIOSCIENCES, INC. 2656 STATE STREET CARLSBAD CA 92008 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 7.60 2023-01-01 4 A 0 32800 0.00 A 2032-12-31 Common Stock 32800 32800 D Stock Option (Right to Buy) 7.60 2023-01-01 4 A 0 328000 0.00 A 2032-12-31 Common Stock 328000 328000 D 25% of the shares subject to the option shall vest on January 1, 2024, and 1/36th of the remaining number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date. The option vests based on achievement of a performance objective. /s/ Ali D. Fawaz, Attorney-in-Fact 2023-01-03